Carregant...

Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C.

In an analysis of the clinical and laboratory variables that can influence the response to interferon alfa-2b treatment, 48 patients with chronic hepatitis C virus infection received interferon 5 million units (MU) subcutaneously three times weekly for eight weeks followed by 3 MU three times weekly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pérez, R, Pravia, R, Linares, A, Rodríguez, M, Lombraña, J L, Suárez, A, Riestra, S, Navascués, C A, Rodrigo, L
Format: Artigo
Idioma:Inglês
Publicat: 1993
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1374042/
https://ncbi.nlm.nih.gov/pubmed/8314482
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!